TSC1 oncogenic variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | TSC1 oncogenic variants | Renal Angiomyolipoma | Everolimus | |
| FDA (2) | TSC1 oncogenic variants | Subependymal Giant Cell Astrocytoma | Everolimus |